Last updated on March 2017

Study Seeking Patients with Schizophrenia


Brief description of study

Study Seeking Patients with Schizophrenia

Detailed Study Description

A Randomized, Open-label, Multiple-dose, Parallel Design, Comparative Bioequivalence Study of Paliperidone Palmitate Extended-Release Injectable Suspension (156 mg/1.0 mL) Versus Invega Sustenna® (paliperidone palmitate) Extended-Release Injectable Suspension (156mg/1.0 mL) in Schizophrenia Patients Already Stabilized on Paliperidone Palmitate

Clinical Study Identifier: TX148352

Contact Investigators or Research Sites near you

Start Over

Segal Institute for Clinical Research

Segal Institute for Clinical Research
Hollywood, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.